Naglazyme RSA ends, 20.6% price cut from March

The MOHW promotes drug reimbursement list revision in February

Vimizim was cut by 2.3% because of heavy usage. Esoduo 40/800mg was voluntarily lowered 15%

Insurance prices have fallen by more than 20% since March, when Naglazyme (Galsulfaze) by Samoh Pharmaceutical has concluded a risk-sharing contract (RSA) agreement.

 

According to pharmaceutical companies' strategies, such as price competition, there are a total of eight products that will be lowered on their own benefits next month.

 

According to the industry on the 19th, the Ministry of Health and Welfare is pursuing ‘the revision of drug reimbursement list and the upper price limits’.

 

The criteria for application are as follows, but the timing of application differs depending on the product.

 

◆Naglazyme’s RSA terminated= Samoh’s Naglazyme with the end of the RSA, is applied as regular reimbursement.

 

The drug was not easily covered because it was expensive until now.

 

In the past, the government increased the accessibility by registering the drug in insurance as a refund pharmacy negotiation pilot project, and introduced the RSA in Korea, and maintained the drug access on the RSA track in March 2016 after the end of the project.

 

The RSA contract lasted for four years, and in preparation for the termination of the drug contract, the NHIS negotiated a drug price on a general track with the company.

 

Negotiations were priced at ₩1,492,815 per 5mg/ml, 20.6% lower than RSA price.

 

The new drug price starts in March shortly after the RSA contract expires.

 

◆Lowered the upper limit due to the price-volume agreement negotiation conclusion= This time, there are a total of 1 drug for which the price is lowered after negotiating with the NHIS.

 

The government is conducting post management of drug prices through Price-Volume agreement linkage, which lowers drug prices by re-negotiating drugs with higher anticipated dosages and claims compared to those listed on drug insurance.

 

Samoh's Vimizim is a new drug that is listed as a drug price negotiation, and the same product group charges are more than 30% higher than the expected billing amount.

 

Price-Volume agreement system(Type Ka) has been applied.

 

Here, the same product group means a drug having the same company name, route of administration, ingredient, and dosage form.

 

The closing price of the negotiations was ₩995,661, 2.3% lower than the previous price.

 

New drug price will be effective from June 1.

 

◆Voluntary upper limit adjustment (voluntary lowering)= A total of eight items will be lowered as the pharmaceutical company voluntarily decides to lower its insurance price.

 

The government calculates and re-adjusts a manufacturer, a consigned manufacturer, or an importer to apply for a price cut at a price lower than the listed maximum drug price.

 

In general, it is a measure of cuts in line with its policies following market competition.

 

Looking at the items, Chong Kun Dang's Esoduo 40/800mg drops by 14.7% from ₩1,078 to ₩920, and Huon's Cinacal from ₩2,267 to ₩2,020 by 10.9%, respectively.

 

Celltrion’s Truxima dropped 6.1% from ₩871,323 to ₩817,823, and Jinyang Pharmaceutical's Jinicough drops 2.9% from ₩102 to ₩99.

 

New drug pricing will begin next month.

 

◆Preservation of production cost of shortage prevention drugs= A total of two drugs are designated as shortage prevention drugs or the price has been preserved.

 

The government designates drugs that are necessary for patient care or are not profitable and that manufacturers, consigned manufacturers, or importers avoid production or import, drugs that require the preservation of production and import costs as a shortage prevention drug and preserves production costs.

 

Myung In Pharm’s Vivaquin is the drug that raised the upper limit due to the conservation of production cost, It is up 21.2% from ₩255 to ₩309.

 

In addition, Shin Poong’s Malafree was designated as a cost-preserving drug.

 

The drug price is ₩309 per tablet.

 

New drug prices will be applied from next month.